.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Federal Trade Commission
Argus Health
Chinese Patent Office
Medtronic
Merck
Mallinckrodt
UBS
Express Scripts
McKesson

Generated: September 26, 2017

DrugPatentWatch Database Preview

Orion Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for ORION PHARMA, and when can generic versions of ORION PHARMA drugs launch?

ORION PHARMA has two approved drugs.

There are three US patents protecting ORION PHARMA drugs.

There are ninety-eight patent family members on ORION PHARMA drugs in forty-one countries.

Summary for Applicant: Orion Pharma

Patents:3
Tradenames:7
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orion Pharma
STALEVO 150
carbidopa; entacapone; levodopa
TABLET;ORAL021485-003Jun 11, 2003ABRXYesNo► Subscribe► SubscribeY ► Subscribe
Orion Pharma
STALEVO 75
carbidopa; entacapone; levodopa
TABLET;ORAL021485-005Aug 29, 2008ABRXYesNo► Subscribe► SubscribeY ► Subscribe
Orion Pharma
STALEVO 50
carbidopa; entacapone; levodopa
TABLET;ORAL021485-001Jun 11, 2003ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Orion Pharma
STALEVO 150
carbidopa; entacapone; levodopa
TABLET;ORAL021485-003Jun 11, 2003ABRXYesNo► Subscribe► SubscribeY ► Subscribe
Orion Pharma
STALEVO 100
carbidopa; entacapone; levodopa
TABLET;ORAL021485-002Jun 11, 2003ABRXYesNo► Subscribe► SubscribeY ► Subscribe
Orion Pharma
STALEVO 50
carbidopa; entacapone; levodopa
TABLET;ORAL021485-001Jun 11, 2003ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Orion Pharma
STALEVO 125
carbidopa; entacapone; levodopa
TABLET;ORAL021485-006Aug 29, 2008ABRXYesNo► Subscribe► SubscribeY ► Subscribe
Orion Pharma
STALEVO 200
carbidopa; entacapone; levodopa
TABLET;ORAL021485-004Aug 2, 2007ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Orion Pharma
STALEVO 75
carbidopa; entacapone; levodopa
TABLET;ORAL021485-005Aug 29, 2008ABRXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Orion Pharma

Paragraph IV activity for ORION PHARMA drugs

Drugname Dosage Strength Tradename Submissiondate
carbidopa, levodopa and entacapone
Tablets18.75 mg/75 mg/200 mg and 31.25 mg/125 mg/200 mg
STALEVO 75
5/19/2009
carbidopa, levodopa and entacapone
Tablets18.75 mg/75 mg/200 mg and 31.25 mg/125 mg/200 mg
STALEVO 125
5/19/2009
carbidopa, levodopa and entacapone
Tablets50 mg/200 mg/200 mg
STALEVO 200
8/28/2008
carbidopa, levodopa and entacapone
Tablets12.5 mg, 50 mg and 200 mg
STALEVO 50
8/5/2008
carbidopa, levodopa and entacapone
Tablets25/100/200 mg and 37.5/150/200 mg
STALEVO 100
6/29/2007
carbidopa, levodopa and entacapone
Tablets25/100/200 mg and 37.5/150/200 mg
STALEVO 150
6/29/2007
entacapone
Tablets200 mg
COMTAN
4/11/2007

International Patent Family for Orion Pharma Drugs

Country Document Number Estimated Expiration
Denmark1189608► Subscribe
Poland197818► Subscribe
Indonesia29026► Subscribe
Malaysia124394► Subscribe
Estonia04657► Subscribe
China1358090► Subscribe
Germany69913714► Subscribe
Australia5830600► Subscribe
Brazil9913681► Subscribe
Brazil0011867► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Chubb
AstraZeneca
Harvard Business School
US Army
Farmers Insurance
Colorcon
Merck
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot